A detailed history of Mariner, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Mariner, LLC holds 189,969 shares of AXGN stock, worth $4.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
189,969
Previous 192,088 1.1%
Holding current value
$4.49 Million
Previous $2.08 Million 62.62%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$10.77 - $17.84 $22,821 - $37,802
-2,119 Reduced 1.1%
189,969 $3.39 Million
Q2 2025

Aug 14, 2025

BUY
$9.29 - $17.81 $441,776 - $846,936
47,554 Added 32.9%
192,088 $2.08 Million
Q1 2025

May 15, 2025

BUY
$14.56 - $20.11 $2.1 Million - $2.91 Million
144,534 New
144,534 $2.67 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $1B
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.